Neuberger Berman Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.6M | Sell |
181,853
-245,659
| -57% | -$61.1M | 0.03% | 496 |
|
|
2025
Q4 | $118M | Sell |
427,512
-17,883
| -4% | -$4.89M | 0.09% | 275 |
|
|
2025
Q3 | $117M | Sell |
445,395
-27,492
| -6% | -$6.68M | 0.09% | 299 |
|
|
2025
Q2 | $103M | Buy |
472,887
+39,451
| +9% | +$8.43M | 0.08% | 303 |
|
|
2025
Q1 | $97M | Buy |
433,436
+52,370
| +14% | +$14.4M | 0.08% | 301 |
|
|
2024
Q4 | $125M | Buy |
381,066
+4,663
| +1% | +$1.47M | 0.1% | 245 |
|
|
2024
Q3 | $113M | Sell |
376,403
-44,201
| -11% | -$13.5M | 0.09% | 264 |
|
|
2024
Q2 | $139M | Sell |
420,604
-67,730
| -14% | -$23.9M | 0.11% | 222 |
|
|
2024
Q1 | $193M | Sell |
488,334
-56,098
| -10% | -$20.8M | 0.16% | 173 |
|
|
2023
Q4 | $192M | Sell |
544,432
-58,560
| -10% | -$20.7M | 0.17% | 165 |
|
|
2023
Q3 | $226M | Sell |
602,992
-118,858
| -16% | -$46M | 0.21% | 131 |
|
|
2023
Q2 | $276M | Sell |
721,850
-242,310
| -25% | -$86.6M | 0.25% | 99 |
|
|
2023
Q1 | $334M | Sell |
964,160
-13,083
| -1% | -$3.82M | 0.31% | 77 |
|
|
2022
Q4 | $230M | Buy |
977,243
+217
| +0% | +$51.4K | 0.23% | 121 |
|
|
2022
Q3 | $240M | Sell |
977,026
-10,988
| -1% | -$3.35M | 0.25% | 98 |
|
|
2022
Q2 | $299M | Sell |
988,014
-83,198
| -8% | -$27.1M | 0.3% | 79 |
|
|
2022
Q1 | $440M | Sell |
1,071,212
-44,863
| -4% | -$17.6M | 0.37% | 53 |
|
|
2021
Q4 | $515M | Sell |
1,116,075
-131,464
| -11% | -$56.6M | 0.4% | 46 |
|
|
2021
Q3 | $523M | Sell |
1,247,539
-37,642
| -3% | -$15.9M | 0.46% | 30 |
|
|
2021
Q2 | $456M | Sell |
1,285,181
-61,445
| -5% | -$20.3M | 0.4% | 43 |
|
|
2021
Q1 | $377M | Sell |
1,346,626
-298,213
| -18% | -$85.3M | 0.36% | 43 |
|
|
2020
Q4 | $464M | Sell |
1,644,839
-277,336
| -14% | -$77.8M | 0.48% | 31 |
|
|
2020
Q3 | $527M | Sell |
1,922,175
-24,500
| -1% | -$6.48M | 0.62% | 15 |
|
|
2020
Q2 | $441M | Sell |
1,946,675
-200,776
| -9% | -$39.4M | 0.55% | 22 |
|
|
2020
Q1 | $327M | Sell |
2,147,451
-128,255
| -6% | -$19.7M | 0.5% | 31 |
|
|
2019
Q4 | $342M | Sell |
2,275,706
-78,637
| -3% | -$11.4M | 0.4% | 46 |
|
|
2019
Q3 | $334M | Sell |
2,354,343
-127,129
| -5% | -$17.5M | 0.41% | 48 |
|
|
2019
Q2 | $311M | Sell |
2,481,472
-131,087
| -5% | -$15.5M | 0.37% | 56 |
|
|
2019
Q1 | $288M | Sell |
2,612,559
-61,715
| -2% | -$6.42M | 0.35% | 61 |
|
|
2018
Q4 | $262M | Sell |
2,674,274
-233,333
| -8% | -$25.3M | 0.37% | 54 |
|
|
2018
Q3 | $359M | Sell |
2,907,607
-144,733
| -5% | -$16.2M | 0.41% | 51 |
|
|
2018
Q2 | $303M | Sell |
3,052,340
-118,840
| -4% | -$10.9M | 0.33% | 65 |
|
|
2018
Q1 | $280M | Sell |
3,171,180
-239,627
| -7% | -$22.4M | 0.32% | 69 |
|
|
2017
Q4 | $337M | Sell |
3,410,807
-207,777
| -6% | -$20.4M | 0.39% | 46 |
|
|
2017
Q3 | $348M | Sell |
3,618,584
-127,682
| -3% | -$11.6M | 0.44% | 31 |
|
|
2017
Q2 | $354M | Sell |
3,746,266
-209,135
| -5% | -$19.2M | 0.45% | 31 |
|
|
2017
Q1 | $323M | Sell |
3,955,401
-34,898
| -0.9% | -$2.92M | 0.42% | 42 |
|
|
2016
Q4 | $338M | Sell |
3,990,299
-157,168
| -4% | -$12.4M | 0.45% | 33 |
|
|
2016
Q3 | $309M | Sell |
4,147,467
-96,745
| -2% | -$7.68M | 0.42% | 44 |
|
|
2016
Q2 | $322M | Sell |
4,244,212
-326,645
| -7% | -$23.8M | 0.44% | 43 |
|
|
2016
Q1 | $317M | Sell |
4,570,857
-225,643
| -5% | -$13.6M | 0.44% | 45 |
|
|
2015
Q4 | $289M | Sell |
4,796,500
-410,130
| -8% | -$24.7M | 0.38% | 66 |
|
|
2015
Q3 | $282M | Sell |
5,206,630
-122,525
| -2% | -$7.14M | 0.36% | 66 |
|
|
2015
Q2 | $310M | Sell |
5,329,155
-189,185
| -3% | -$10.6M | 0.34% | 71 |
|
|
2015
Q1 | $332M | Sell |
5,518,340
-94,403
| -2% | -$5.03M | 0.35% | 66 |
|
|
2014
Q4 | $299M | Buy |
5,612,743
+95,978
| +2% | +$4.8M | 0.31% | 85 |
|
|
2014
Q3 | $247M | Buy |
5,516,765
+41,331
| +0.8% | +$1.76M | 0.25% | 108 |
|
|
2014
Q2 | $231M | Buy |
5,475,434
+63,206
| +1% | +$2.71M | 0.23% | 119 |
|
|
2014
Q1 | $238M | Sell |
5,412,228
-32,544
| -0.6% | -$1.53M | 0.24% | 114 |
|
|
2013
Q4 | $267M | Buy |
5,444,772
+255,306
| +5% | +$11.9M | 0.27% | 90 |
|
|
2013
Q3 | $214M | Sell |
5,189,466
-153,922
| -3% | -$5.87M | 0.24% | 120 |
|
|
2013
Q2 | $188M | Buy |
+5,343,388
| New | +$176M | 0.22% | 129 |
|
Other funds holding WST
VCM
VPM
GIM
Neuberger Berman Group's WST Position: Q1 2026 in Review
Neuberger Berman Group reduced its West Pharmaceutical (WST) stake by 57% in Q1 2026, selling an estimated $61.1M and leaving 181,853 shares worth $45.6M. The position accounts for 0.03% of the portfolio, ranked #496.
Neuberger Berman Group first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $527M in Q3 2020. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Neuberger Berman Group held 181,853 shares of West Pharmaceutical worth $45.6M as of Q1 2026.
- Neuberger Berman Group sold 245,659 West Pharmaceutical shares in Q1 2026, an estimated $61.1M.
- West Pharmaceutical made up 0.03% of Neuberger Berman Group's portfolio in Q1 2026, its #496 holding.
- Neuberger Berman Group first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
- Neuberger Berman Group's West Pharmaceutical position peaked at $527M in Q3 2020.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.